Reply: Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?

Mov Disord Clin Pract. 2022 Oct 3;9(8):1154-1155. doi: 10.1002/mdc3.13571. eCollection 2022 Nov.

Stephen A Ryan^{1

2}, Mario Masellis^{1

3}, Juan Bilbao⁴, Julia Keith⁴, Ekaterina Rogaeva⁵, Sandra E Black^{1

3

6}, Anthony E Lang^{3

7}, Galit Kleiner^{3

8}

¹ L.C. Campbell Cognitive Neurology Research Unit Sunnybrook Health Sciences Centre Toronto Ontario Canada.
² Division of Neurology, Department of Medicine Queens University Kingston Ontario Canada.
³ Division of Neurology, Department of Medicine University of Toronto Toronto Ontario Canada.
⁴ Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario Canada.
⁵ Tanz Centre for Research in Neurodegenerative Disease University of Toronto Toronto Ontario Canada.
⁶ Hurvitz Brain Sciences Program, Sunnybrook Research Institute Toronto Ontario Canada.
⁷ Edmond J Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital University Health Network Toronto Ontario Canada.
⁸ Baycrest Centre for Geriatric Care Toronto Ontario Canada.

No abstract available